Keeping Current CME cover art

All Episodes

Keeping Current CME — 686 episodes

#
Title
1

Carotid Ultrasound: Seeing Vascular Age

2

The Practical Community Colorectal Cancer Clinic: Aligning Biomarker Analysis to Treatment Selection

3

Empowering Frontline Care in IBS-C: Moving Beyond OTC Therapies

4

The Right Fit: Personalizing COPD Device Selection Across the Patient Journey

5

When Monotherapy Fails in Depression: An Evidence-Based Update

6

From Symptoms to Success: Real-World Cases in Patient-Centered IBS-C Care

7

Multidisciplinary Management of Metabolic Dysfunction-Associated Steatohepatitis

8

Advancing Care in HER2-Mutated NSCLC: Evidence, Diagnostics, and Future Directions

9

The Mechanisms Behind Rapid-Acting Treatments for Major Depressive Disorder

10

Cracking the Code With Coronary Artery Calcium (CAC)

11

Cracking the Code: Optimizing Outcomes in All Patients With High-Risk HR+/HER2-Negative Early Breast Cancer

12

Breaking the OTC Cycle: Optimizing Prescription Therapy for IBS-C in Everyday Practice

13

Challenging the Confines of Risk of Recurrence in High-Risk HR+/HER2- Early Breast Cancer

14

Lessons From the Real World: Treating High Risk HR+/HER2- Breast Cancer According to the Latest Evidence

15

Beyond the Headlines: A Critical Look at MRA Evidence in HFpEF

16

Up Front Antibody-Drug Conjugates: Shifting the Paradigm in Metastatic Triple-Negative Breast Cancer Treatment

17

Biosimilars: What Primary Care Needs to Know About Biosimilars in Practice

18

Enhancing Clinical Understanding of Oral SERD-Based Therapies for Patients With ER-Positive/HER2-Negative MBC

19

Maximizing Therapeutic Efficacy Prior to Epilepsy Surgery: Considerations for the Selection of Antiseizure Medications

20

Expanding the Actionability of Crucial Biomarkers in Your Community-Based Colorectal Cancer Clinic

21

Identifying Suboptimally Managed Erosive Esophagitis in Clinical Practice

22

Steps for Personalized and Collaborative Decision-Making in HER2-Mutated NSCLC

23

The Nurse View: Evolution of Anti-HER2 Therapies in Gastroesophageal Adenocarcinoma

24

Progressive Familial Intrahepatic Cholestasis: Case From the Community

25

Rapid Reports in Dravet Syndrome: Synthesizing Pipeline Developments

26

Demystifying Bronchiectasis: Rethinking Standards of Care

27

Breaking Ground in Gastroesophageal Adenocarcinoma: First-Line Anti-HER2 Therapy for Advanced Disease

28

Chronic Lymphocytic Leukemia (CLL): Review of Combination Approaches

29

Quick Talk on ES-SCLC: What Community Clinicians Need to Know Now

30

Best Practices for Integrating Biosimilars Into Clinical Practice: An Interprofessional Perspective

31

CAR T Cells in SLE: A New Frontier in Autoimmunity

32

Case by Case: Managing ES-SCLC in the Real World Through Patient Partnership

33

Utilizing Automated Insulin Delivery to Close Gaps in Type 2 Diabetes Care

34

Empowering Choices in Moderate to Severe Asthma: Partnering With Patients for Optimal Treatment Decisions

35

Current and Future Oral SERD Strategies in the Management of ER-Positive/HER2-Negative MBC: Analyzing the Clinical Data

36

COPD Device Decisions That Matter: Who Really Benefits From Nebulized Therapy?

37

Game Over: Stop the Ongoing Seizure

38

Genetic Testing for Dravet Syndrome: A Patient–Physician Communication Module

39

Patient-Centered Approaches to Indolent Systemic Mastocytosis: Advancing Care and Reducing Diagnostic Delays

40

Highlights From the Annual Neuro-Oncology Conference: Redefining IDH-Mutant Glioma Management

41

Empowering Nursing Care in Acromegaly: Strategies for Enhanced Diagnosis and Management

42

Navigating Advances in IgA Nephropathy: Key Developments for Therapies Targeting the B-Cell Pathway

43

Precision Oncology in HER2-Mutated NSCLC: Strategies for Today and Tomorrow

44

From Approval to Practice: Expert Approaches to Infusion Site Reactions in Parkinson Treatment

45

Real-Time Insights Into the Diagnosis and Management of ATTR: From Genetic Insight to Therapeutic Innovation

46

Building the Case for Nonsteroidal Topical Atopic Dermatitis Treatments

47

Case Review in Narcolepsy and Idiopathic Hypersomnia: Integrating Treatment Decisions That Prioritize Sleep Quality and Cardiovascular Risk

48

Highlights From the Annual Neuro-Oncology Conference: Integrating IDH Inhibitor Therapy Into Glioma Care

49

Navigating Advances in TRK Fusion-Positive Cancers: A Collaborative Journey From Testing to Therapy

50

Elevating Anemia Care: New Strategies for Dialysis-Dependent Chronic Kidney Disease

51

The Cardio-Kidney-Metabolic Collective: Piecing Multidisciplinary and Patient Insights to Optimize Care

52

Spotlight on Obstructive Sleep Apnea: Focus on HCP-Patient Communication and Shared Decision-Making

53

Collaborative Care in Pediatric Atopic Dermatitis: A Multidisciplinary Approach

54

Advancements in Treatment for Inflammatory Conditions: The Role of Interdisciplinary Coordination in Effective Care Planning

55

JAK Inhibitors in Rheumatoid Arthritis: Overcoming Challenges and Maximizing Impact

56

Exploring JAK Inhibitors for Atopic Dermatitis

57

Mastering Oral Therapies in CLL and MCL: Essential Strategies and Insights for Nurses

58

Expert Conversations in Narcolepsy: Improving Sleep Quality While Considering Cardiovascular Comorbidities

59

The Genotype-Phenotype Connection in Dravet Syndrome: Preparing for the Future

60

HER2 Evolution in Gastroesophageal Cancer: New Therapies and Optimized Outcomes

61

Patients Progressing on an AI ± CDK4/6 Inhibitors: From Biomarkers to Treatment Strategies

62

Advancing COPD Care Through Precision Medicine and Patient Empowerment

63

The Metabolic Dysfunction-Associated Steatohepatitis Countdown

64

From Screening to Action: Addressing Chronic Kidney Disease to Reduce Cardiovascular Risk

65

The COVID Countdown: The Latest in Safeguarding Protection and Treatment for Vulnerable Populations

66

Cardiovascular Safety and Symptom Management of Narcolepsy and Idiopathic Hypersomnia

67

Narcolepsy and Idiopathic Hypersomnia as 24-Hour Conditions: Prioritizing Sleep Quality

68

Constipation Clash: An IBS-C Challenge

69

Communicating to Enhance Care Through Data and Patient Experience: ER-Positive/HER2-Negative Metastatic Breast Cancer Edition

70

Highlights From San Francisco: The Evolving Role of The Radiation Oncologist in Lower-Grade Glioma Care

71

Mind Matters - Expert Insights on the Importance of Mental Wellness for Patients Living With Inflammatory Arthritic Conditions

72

Expanding Automated Insulin Delivery to Type 2 Diabetes: Where Are We Now?

73

Liver MRI: News From the Front Lines

74

Between the Lines of Depression: Navigating Diagnostic Nuances and Treatment Strategies

75

Elevating the Therapeutic Needs of People With Huntingtons Disease: A Look Into the Future

76

International Voices in Alzheimer's Disease: Regional Perspectives on Diagnosis and Management

77

ESR1 Mutation Testing in Breast Cancer: Setting the Standard for Personalized Oncology?

78

Breathing New Life Into COPD: Empowering Patients Through Therapy Innovation

79

Clinical Pearls: Navigating Challenges in Anemia of Dialysis-Dependent Chronic Kidney Disease

80

Missed and At-Risk: Rewriting the Cervical Cancer Screening Story

81

Optimizing Cardiovascular-Kidney-Metabolic Care With Interdisciplinary Insights

82

HER2-Positive Gastroesophageal Adenocarcinoma and Biliary Tract Cancer: Updates and Insights

83

Debating New IBD Treatments: Ready, Set, Go!

84

Chronic Rhinosinusitis With Nasal Polyps Reimagined: Bridging Surgery and Biologics to Improve Patient Outcomes

85

Endocrine Therapies in ER-Positive/HER2-Negative MBC: Understanding Their Benefits and Limitations to Optimize Treatment Selection

86

The Clock Is Ticking: Optimizing Ongoing Seizure Response

87

Beyond the Inhaled Corticosteroid Plateau: Targeted Strategies for Moderate to Severe Asthma

88

Inflammatory Bowel Disease: Why Mental Health and Wellness Matter

89

Bridging the Gap: Case-Based Exploration of Current and Emerging Therapies in IgA Nephropathy

90

Atopic Dermatitis: It's More Than Skin Deep

91

Top 10 Clinical Pearls: Outlining Optimal Care for Nasopharyngeal Carcinoma

92

Atopic Dermatitis Balancing Act: Exploring the Safety and Efficacy of JAK Inhibitors in Practice

93

Diagnosing Rheumatoid Arthritis Early: Integrating Serologic and Biomarker Tests

94

An Expert Discussion of Key New Data in CLL and MCL: How May It Impact Future Practice?

95

Coming Together in the Community: Discussing Nasopharyngeal Carcinoma Care Strategies

96

Changing the Game in Hepatitis B Care: Breakthroughs and Advances to Optimize Patient Outcomes

97

Navigating the New Era of Heart Failure Treatment: Practical Use of Nonsteroidal Mineralocorticoid Receptor Antagonists

98

Framing the Future of Topical Therapies for Atopic Dermatitis

99

Recognizing and Managing Variant ATTR Amyloidosis: Focus on Early Clues in Black Patients

100

Revolutionizing Postpartum Depression Care: Expert Insights and Patient Perspectives on the Diagnostic Journey and Treatment Approaches

101

Expert Perspectives on the Latest Clinical Trial Updates in HR-Positive, HER2-Negative Early Breast Cancer

102

Considerations for Shared Decision-Making on the Use of Anti-Amyloid Therapies in Clinical Practice

103

Precision Imaging in Cardiac MRI: Late Gadolinium-Enhanced Imaging

104

Beat the Clock: Can We Achieve Faster Control of Acute Seizures?

105

Implementing the Metabolic Dysfunction–Associated Steatohepatitis Care Pathway in Practice

106

Precision Imaging in MRI: Brain Imaging

107

MRI Workup of Ischemic Heart Disease: Insights and Innovations

108

Celebrating Advances and Addressing Inadequacies in Hypercortisolism Management in the Modern Era

109

Biomarkers, Genetics, and Anti-Amyloid Therapies for Early Stages of AD

110

A How-To Guide to the Use of Anti-Amyloid Therapies: Recommendations for Setting Up Your Practice

111

The Role of Neuroradiology in the Ongoing Safety Monitoring and Care of Patients Receiving an Anti-Amyloid Therapy for Early Alzheimer's Disease

112

Postpartum Depression: An Expert Quickfire Dialogue on Diagnosis

113

Patients' Insights Illuminated: A Rapid-Fire Dive Into CLL and MCL

114

Implementing Comprehensive Genomic Profiling Into Your Oncology Care Plan

115

The Patient With T2D and Early-Stage CKD in Primary Care

116

Empowering Mothers: Early Identification and Treatment of Postpartum Depression

117

Optimizing Outcomes for Thyroid Cancer With NTRK Gene Fusions: Precision Care, Patient Impact

118

Latest Advances in Tumor-Agnostic Strategies for NTRK Fusion-Positive Cancer: Translating Science Into Clinical Practice

119

Visual Insights: Exploring the Disease-Modifying Effects of Anti-APRIL Treatments for IgA Nephropathy

120

Transforming Gastric and GEJ Cancer Care With Perioperative Immunotherapy: Latest Updates From Chicago

121

Hereditary Angioedema Headlines: Early Intervention Strategies for Managing Attacks and Improving Patient Outcomes

122

Highlights From the Annual Oncology Meeting: Clinical Integration of Therapeutic Innovations in Glioma

123

Med Feud Challenge in Narcolepsy: The Winning Formula for Personalizing Treatment and Prioritizing Safety

124

Case Challenges in Rett Syndrome: Reducing the Time to Genetic Testing, Diagnosis, and Treatment

125

Precision Imaging in Liver MRI

126

Alzheimer's Disease Diagnosis, Response, and the Neuroradiologist and Nuclear Medicine Specialist: Tactics, Strategies, and Best Practices

127

Collaborative Care: Navigating Multidisciplinary Management of CLL and MCL for Optimal Patient Outcomes

128

New Standards in Diffuse Lower-Grade Gliomas: Integrative Management From Surgery to Survivorship

129

Tackling Complex HIV Cases: Navigating Drug-Drug Interactions With Long-Acting Injectables in HIV Care Today

130

The Evolving Role of Nonsteroidal MRAs for Heart and Kidney Disease

131

A Review of the Scientific Basis of Alzheimer's Disease for Neuroradiologists and Nuclear Medicine Specialists

132

Management of Early Alzheimer's Disease: Merging Clinical Data and Clinical Decision-Making

133

Maximizing Success in HIV Prevention and Treatment: Reframing Drug–Drug Interactions in the Era of Long-Acting Injectables

134

Breaking News: What You're Itching to Know About Primary Biliary Cholangitis and Pruritus

135

How Do I Know If Renal Denervation Is Right for My Hypertension Patient?

136

From Diagnosis to Treatment: Multidisciplinary Pathways for Effective Nasopharyngeal Carcinoma Care

137

Case-Based Insights on Managing Constipation

138

Unlocking Skin Glycation: Bridging Science, Data, and Clinical Impact

139

New and Emerging Adjunctive Treatments for Major Depressive Disorder

140

Unraveling the Perplexities of Mixed Features in Mood Disorders: Expert Insights

141

The RSV Rundown: Expert Reports on Current Insights and Vaccine Recommendations

142

Precision in Practice: Essential Strategies for Genomic Testing in NSCLC

143

Applying Recent Data to Your Everyday Practice in Biliary Tract Cancers

144

Primary Care Strategies for Reducing Cardiovascular and Kidney Risks in Diabetes

145

Informing Alzheimer's Disease Referral: Blood-Based Biomarker Evaluation in Primary Care

146

Enhancing Primary Care Confidence in Managing Obstructive Sleep Apnea in Patients With Comorbidities

147

Community Focus: Addressing Gaps and Elevating Care for Patients With Basal Cell Carcinoma

148

Educating, Empowering, and Engaging: A Focus on HER2-Activating Mutations in NSCLC

149

Navigating the Future: A Clinical Roadmap for Anti-Amyloid Therapies in Alzheimer's Disease

150

Hormone Receptor-Positive, HER2-Negative Early Breast Cancer: The Adjuvant Clinical Trial Populations Explained

151

Clinical Trials in CLL and MCL: Expert In-Depth Analysis

152

A Multidisciplinary Approach to Identifying and Managing Cortisol Dysfunction

153

Best Practices for the Multidisciplinary Care of Patients With Early-Stage ALK-Positive NSCLC

154

Preeclampsia Biomarker Screening in Every Trimester

155

How Many Lymph Nodes Are Involved in This Patient With HR-Positive, HER2-Negative Early Breast Cancer?

156

Chronic Myeloid Leukemia: A 2025 Update on Novel Targets and Recent Clinical Data

157

Determining the Risk of Recurrence in HR+/HER2- Early Breast Cancer Without Axillary Dissection

158

The Itch Factor: Troublesome Symptoms and Dermatologic Conditions

159

Unlocking the Path to Optimal Severe Asthma Care: Strategies for Success

160

Clinical Cases in HR-Positive, HER2-Negative Early Breast Cancer: Applying the Latest Evidence

161

Exploring the Role of the Psychiatry Professional in the Care of People With PTSD

162

New Paradigms in Hypertrophic Cardiomyopathy Care Gameshow Challenge: Cardiac Myosin Inhibition

163

Advancing Hyperphosphatemia One Dose at a Time

164

Advancing Care in HSCT-TMA: Strategies for Early Recognition and Management

165

ASH 2024 Highlights of Key Lymphoma Data

166

Moving the Needle in ER-Positive/HER2-Negative Metastatic Breast Cancer: Exploring SERD Strategies to Optimize Outcomes

167

Comprehensive and Personalized Approach to Managing mHSPC: Fitting the Right Pieces for Each Patient

168

Posttraumatic Stress Disorder in Primary Care: Understanding Roles and Responsibilities

169

Emerging IgA Nephropathy Advances: Digging Deep in the B-Cell Pathway

170

Unlocking Minds: Navigating the Labyrinth of Cognitive Impairment Associated With Schizophrenia

171

HER2-Positive Biliary Tract Cancer: New Developments and Future Directions

172

Translating Diagnostic Updates in Agitation in Alzheimer's Disease for the Primary Care Practitioner

173

Putting Posttraumatic Stress Disorder Into Perspective for the Practicing Clinician: A Patient Introduction

174

Deconstructing the Diagnostic Journey: Identifying Bipolar Depression

175

Understanding and Managing Schizophrenia in the Digital Therapeutics World: An Interactive Update

176

Unpacking New Data From 2024 Congresses on Transthyretin Amyloid Cardiomyopathy

177

Critical Decision Points in Bloodstream Infection Management: Evolving Approaches With Rapid Diagnostics

178

Innovations and Breakthroughs in Epinephrine Delivery: Optimizing Outcomes With Early Intervention for Anaphylaxis

179

Recognizing Intersecting Symptoms and Their Implications in Mood Disorders

180

Expert Update on Current and Emerging Pharmacotherapies in Patients With Major Depressive Disorder Who Have Inadequate Response

181

Pediatric TRK Fusion-Positive Cancer: Optimizing Care With TRK Inhibitors

182

Differential Diagnosis of Pediatric Cholestatic Liver Diseases

183

Evolving Treatment Landscape for mHSPC: Latest Clinical Data and Implications for Practice

184

Discussing Key Clinical Decisions in Managing Primary Biliary Cholangitis

185

Managing Gastroesophageal Reflux Disease: Who Is in the Waiting Room?

186

New Frontiers in NSCLC: The Promise and Progress of HER2-Directed Therapies

187

Exploring the Pathophysiological Basis of Post-Traumatic Stress Disorder

188

Back to Basics in Agitation Associated With Alzheimer's Disease: Mechanisms and Implications for Treatment

189

Expert Roundtable on the Use of Anti-Amyloid Therapies for the Treatment of Alzheimer's Disease

190

Reflux Is Everywhere: A Primary Care Guide to Managing Gastroesophageal Reflux Disease

191

Medscape Onsite: Riding the Wave of NSCLC Updates From San Diego

192

Updates on Renal Denervation From the 2024 European Society of Cardiology Guidelines on Hypertension

193

Hidden Unmet Needs in Schizophrenia: What Every Healthcare Professional Needs to Know

194

Spotlight on Liver MRI: Diagnosing and Managing Hepatocellular Carcinoma

195

Modeling Guideline-Concordant Therapy Selection in the Adjuvant Setting for Endometrial Cancer

196

Evolution of HER2-Targeted Therapy in Biliary Tract Cancer

197

Spotlight on Liver MRI: Fatty Liver Disease

198

Cognition in Psychiatry and Schizophrenia: All You Need to Know in 15 Minutes

199

Data Highlights in Alzheimer's Disease From the 2024 AAIC Annual Meeting

200

Mastering Multiplex Testing for Diagnosing Pneumonia: From Interpretation to Application

201

Expert Perspectives on the Future of IgA Nephropathy Treatment

202

Breaking Down the Burden of IgA Nephropathy With Clinician and Patient Perspectives

203

Putting Data Into Context for Congenital Adrenal Hyperplasia Treatment Advances

204

Don't Go With Your Gut: Optimizing GI Infection Management With Rapid Diagnostic Panels

205

The Multiple Layers of Major Depressive Disorder Management: Unravelling the Who, When, and How for Antidepressant Modification

206

Exploring Innovations in Lung Cancer Care: Updates From Chicago

207

Key Clinical Characteristics of IgA Nephropathy to Apply in Practice

208

Building Confidence in Care: Strategies to Address Vaccine Hesitancy in Hispanic Communities

209

Navigating Relapsed/Refractory CLL/SLL Together: Where Disease-, Treatment-, and Patient-Centered Care Unite

210

Navigating Patient-Centered Care of CLL and MCL: Empowering Collaboration and Communication

211

Unmasking Cognitive Impairment and Negative Symptoms in Schizophrenia

212

What's on the Horizon in Atopic Dermatitis? A Focus on OX40-OX40 Ligand-Targeted Therapies

213

Expert Opinions on Treating Metabolic Dysfunction-Associated Steatohepatitis

214

Connecting With the Experts at ASCO 2024: Clinical Pearls and Data Insights About Anti-HER2 Therapies in Biliary Tract Cancer

215

Life With Cardiac Amyloidosis

216

Quiz Time! Test Your Knowledge on Treatments for Gastroesophageal Reflux Disease

217

What's New in the Treatment of Gastroesophageal Reflux Disease and Erosive Esophagitis: Spring Meeting Updates

218

EHA2024 Chronic Lymphocytic Leukemia Preview: The Road Ahead With Targeted Therapies

219

There Are Multiple Ways to Treat R/R CLL or R/R MCL: What Would the Experts Do?

220

Multiple Sclerosis Biosimilars in the United States: How to Communicate With Your Patient for Successful Implementation

221

To Switch or Not to Switch: Patient Case Discussions on Integrating Biosimilars in Multiple Sclerosis Care

222

Enhancing Equitable HIV Care With Long-Acting Injectable Antiretrovirals: Why It Matters

223

International Expert Recommendations for Timely and Accurate Diagnosis of Alzheimer's Disease in Primary Care

224

Case Study in Managing in MASLD/MASH

225

Renal Denervation for High Blood Pressure: Long-Term Control or Short-Term Bandage?

226

Cardiac Implantable Electronic Device (CIED) Infections: How Well Are Patients Really Doing? Real-Time Gaps and Implications for Evidence-Based Care

227

Beyond Positive Symptoms in Schizophrenia: What Else Should We Be Actively Looking Out For?

228

Improving Outcomes in Schizophrenia in Underserved Communities

229

Hepatitis C Screening and Beyond: Role of the Primary Care Team in Addressing Inequities

230

Evolution of the Care of Patients With Advanced Ovarian Cancer

231

Axial Spondyloarthritis Treatment Advancements: Where Do Janus Kinase Inhibitors Fit In?

232

Knowing How and When to Switch Medications in Schizophrenia

233

For Pharmacists: Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

234

Care Pathways for Diagnostic Excellence: Understanding Provider Roles and Responsibilities

235

Evolution of HER2-Targeted Therapy in Gastroesophageal Adenocarcinoma

236

Insights From the Experts on Prescription Digital Therapeutics in Psychiatry

237

Optimizing Treatment Pathways in CLL and MCL: Evaluating and Applying Recent Data on BTK Inhibitors

238

Expert Analysis of Hereditary Angioedema Data: Unlocking Practice Implications From AAAAI

239

Obesity in Childhood and Adolescence: The Pediatrician in Charge?

240

Identify and Act, Part 2: What's New in Managing Homozygous Familial Hypercholesterolemia?

241

Navigating the Management of Epidermolysis Bullosa: A Case-Based Discussion on How to Integrate Novel Therapies Into Clinical Practice

242

Primary Biliary Cholangitis: Targeting New Treatment Goals

243

Community Collaboration: Application of CDK 4/6 Inhibitors in the Treatment of HR-Positive/HER2-Negative Early Breast Cancer

244

What You Always Wanted to Know About Obesity but Never Dared to Ask: Quick Questions and Rapid Replies

245

Selecting Therapies to Optimize Treatment Success in Schizophrenia

246

Evolution of Oncogenic-Driven Early-Stage Resectable NSCLC: Testing and Practical Considerations

247

Which Endpoints Matter Most in Transthyretin Amyloid Cardiomyopathy Trials? Are We Comparing Apples to Apples?

248

Current Unmet Needs in Schizophrenia: Assessing Gaps in Care

249

Cognitive Impairment and Negative Symptoms in Schizophrenia: Recognizing Hidden Disabilities

250

Analyzing the Latest Data for Gonadotropin-Releasing Hormone Agonists and Antagonists in Prostate Cancer: What Does This Mean for the Patient?

251

OncoChallenge in Locally Advanced Head and Neck Cancer: Exploring New Directions

252

Updates on Cardiac Implantable Electronic Device Infections: New Data Driving the Need to Treat and Beat Infection

253

6 Practical Steps to Integrating Long-Acting Injectables for HIV Prevention and Treatment

254

Advances in Topical Treatments for Seborrheic Dermatitis

255

Clinical Debates in Psoriatic Arthritis: Is a JAK Inhibitor Right for This Patient?

256

Evolving Landscape of HR-Positive Metastatic Breast Cancer: A Year in Review

257

The Science of Janus Kinase Inhibitors Across Immunologic Diseases

258

Relapsed/Refractory Multiple Myeloma: A Case-Based Tumor Board

259

Cardiac Amyloidosis: The Red Flags to Consider

260

The Expanding Role of Mutation Testing in Advanced Gastrointestinal Stromal Tumor: From Biology to Therapy Rationale

261

How to Prepare Yourself and Your Practice for Adults With Rare Pediatric-Onset Epilepsies

262

Applying the Evidence: Newer Therapies for Dravet Syndrome and Lennox-Gastaut Syndrome

263

Updates in Breast Cancer From San Antonio 2023: Practice-Changing Data and Clinical Implications

264

Targeting BTK and Bcl-2 for B-Cell Malignancies: Where Are We Moving Toward?

265

Multidisciplinary Team Best Practices to Improve Adherence for High-Risk, HR-Positive/HER2-Negative Early Breast Cancer: Cases From the Community

266

The Age of Respiratory Syncytial Virus Prevention: Empowering Pharmacists to Optimize Disease Protection in Older Adults

267

Essential Facts About Obesity: Effective and Appropriate Use of Novel Weight-Loss Medications

268

Confronting Obesity in Cardiology Care: A Major Driver of Cardiovascular Risk

269

Why Do I Need Adjuvant Therapy? Communicating the Risks for HR-Positive, HER2-Negative EBC at High Risk of Recurrence

270

Understanding the Concerns and Challenges of Patients With HR-Positive/HER2-Negative EBC: Expert Insights and Recommendations

271

Emerging Antibody-Drug Conjugates in Breast Cancer: An Expert Analysis of Promising Therapies

272

Latest Update on HER2-Low Breast Cancer and Implications for Clinical Practice

273

From Symptom to Solution: Best Practices in Syndromic Testing for Improved Patient Outcomes

274

Novel Biologic Therapies for Spondyloarthritis: The Year in Review

275

Relapsed/Refractory Chronic Lymphocytic Leukemia: The Evolving Role of BTK Inhibitors

276

Personalizing Risk Assessment to Enhance Primary Cardiovascular Prevention: From Methods to Interpretation

277

Nonalcoholic Steatohepatitis: Mission Possible!

278

Meeting of the Minds: Addressing the Gray Zone of Immunotherapy for Advanced Non-Small Cell Lung Cancer

279

ROS1-Positive Advanced NSCLC: Sharing Best Practice From the Clinic to Maximize Patient Outcomes

280

What Does It All Mean for Your Practice? Closing Remarks From the Conference Chairs

281

Managing the Borderline-Risk Patient With Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: Shedding Light on the Role of Surgeon, Radiologist, and Oncologist

282

Exploring New Strategies for the Management of Nonalcoholic Steatohepatitis: NOT a Trivial Pursuit

283

Navigating Between Endocrine Therapy, Chemotherapy, and CDK 4/6 Inhibitors for High-Risk HR+/HER2- Early Breast Cancer: The Great Debate

284

Communication Strategies With Caregivers Following the Diagnosis of Rett Syndrome

285

2023 Rett Syndrome Year in Review: Expert Discussion on What's New

286

Keeping It Current: Latest European Updates in Prostate and Bladder Cancer

287

Strategies for Improving Patient Outcomes in Pediatric-Onset Seizures

288

Immunotherapy in Special Populations With Non-Small Cell Lung Cancer: What Would the Oncologist Do?

289

Navigating the Patient Journey for LA SCCHN: A Look at Treatments for Today and Tomorrow

290

Accessible Fertility Care: Breaking the Silence on Infertility

291

Biologic Treatment Selection for Psoriatic Disease in a Complex Treatment Landscape

292

Hidden in Plain Sight: Anticholinergic Burden in Patients With Overactive Bladder

293

Quickfire Updates From Brisbane: Expert Insights on the Latest Data and Implications for HIV Care

294

Practice Pearls for Managing Opioid-Induced Constipation

295

Cardiac MRI: Case Studies in Improving Patient Outcomes

296

To Know Is Better With Rapid Diagnostic Tests: Optimizing Respiratory Infection Management in Urgent Care

297

Great Debates in Primary Cardiovascular Prevention: Evaluating the Role of Aspirin

298

Improving Heart Failure Prognosis: Electronic Health Record Screening Tools to Detect Iron Deficiency

299

Psychiatry Mid-Year Review: Data Highlights on Antipsychotic Therapies

300

Clinical Consult in Nonalcoholic Steatohepatitis: Managing Intermediate- and High-Risk Patients

301

Clinical Pearls for Syndromic Testing: Closing the Loop on Acute Respiratory Infection Management

302

Expert Quickfire: Perspectives on the Burden and Prevention of Shingles

303

Hot Topics in Schizophrenia: Expert Poster Presentations From 2023 Psychiatry Congresses

304

Best Practices in the Identification and Management of Agitation Due to Alzheimer's Disease

305

Current Guidelines for Osteoarthritis: What Are the Practice Implications for Oral NSAIDs?

306

Taking Control of Fertility With Personalized Insights: Leveling the Fertility Care Continuum

307

The Patient's Journey With Type 1 Diabetes: From Screening to Diagnosis and Management

308

Raising the Bar: Optimizing Outcomes in Spondyloarthritis

309

Immunoglobulin A Nephropathy -- Targeting Gut Mucosal Immunity to Modify the Course of the Disease

310

Expert Insights Into the Biosafety of Oncolytic Immunotherapies and Their Combination With Immune Checkpoint Inhibitors

311

Deciphering Alzheimer's Disease Pathogenesis: From Signaling Pathways to Current Therapeutic Targets

312

A Detective Journey for Nephrologists: Practical Approaches to Differential Diagnosis of Rare Kidney Diseases

313

Ultrafast, Abbreviated, and Conventional Breast MRI: Who and Why?

314

Clinical Consult in Nonalcoholic Steatohepatitis: Are Your Patients at Risk?

315

Clinical Pearls in Diagnostic Stewardship: From Knowledge to Application

316

Nursing and Pharmacy Perspectives: Strategies for Optimizing the Care of Patients With Metastatic Melanoma

317

Looking Ahead in Complement-Mediated Kidney Diseases: What Clinical Questions Do Current Trials Aim to Answer

318

Multiparametric MRI for Active Surveillance of Prostate Cancer

319

Mechanisms for Delaying/Preventing Type 1 Diabetes Clinical Onset

320

Novel Strategies for Cardiorenal Risk Control in Patients With T2D: Quick Questions, Rapid Replies

321

Congenital Cytomegalovirus Management: What Does the Care Team Look Like?

322

Untangling the Role of Muscarinic Receptors in Psychotic Disorders

323

Acute Myeloid Leukemia Beyond FLT3 and IDH: The Role of Non-Targetable Driver Mutations

324

Socioeconomic Disparities of Cytomegalovirus

325

Facing the Challenge of Multiply Relapsed Myeloma in the Community Setting

326

Metastatic Melanoma: Incorporating Lymphocyte-Activation Gene 3 Inhibitors Into the Treatment Paradigm

327

Clinical Trends in MR Vessel Wall Imaging

328

Merging Established and Emerging Therapeutics in Rett Syndrome: Case Conversations

329

Is Cytomegalovirus a Silent Threat for Parents and Children? Understanding the Burden and Consequences

330

Let's Talk Relapsed/Refractory Chronic Lymphocytic Leukemia: Expert Perspectives on Reversible BTK Inhibitors

331

Wilson Disease: What's on the Horizon?

332

Clinical Updates in Hereditary Breast Cancer: Highlights From Vienna 2023

333

Management of HR-Positive/HER2-Negative Early Breast Cancer: Taking Direction From the Updated Guidelines

334

A Roadmap to Elimination: Integrating Hepatitis C Diagnosis and Management Into Everyday Primary Care

335

Practical Management of Early Relapses in the Myeloma Clinic

336

Data Deep Dive: What's New in Biologic Therapies for Psoriatic Arthritis and Axial Spondyloarthritis?

337

Diagnostic Pathways in Agitation Associated With Alzheimer's Disease

338

The Gut-Kidney Axis in IgAN: Can Novel Therapies Change the Disease Paradigm?

339

Diabetes Dialogue Part 1: Pursuing Holistic Treatment Concepts With GLP-1 Receptor Agonists in Primary Care

340

What You Didn't Learn in Medical School About Cannabinoids

341

Staying Alert to Infertility: Key Hormonal Indicators

342

BTK Inhibitors for CLL and MCL: What the Latest Data Mean for Our Patients

343

Optimizing Outcomes for Spondyloarthritis: Focus on Interleukin-23/-17 Inhibitors

344

Depicting LAG3: Exploring a New Target in Metastatic Melanoma

345

Updates on Treating Newly Diagnosed Multiple Myeloma

346

Exploring Data on Emerging Treatments for Primary Biliary Cholangitis

347

Acute Myeloid Leukemia and the Role of FLT3 Inhibitors: Best Practices for the Interprofessional Care Team

348

New Automated Insulin Delivery Recommendations Coming in HOT!

349

Risk-Adapted Management of Multiple Myeloma in the Era of Modern Therapy

350

Intranasal Sprays for Allergy Relief: Clearing the Air

351

Novel Nonsteroidal Mineralocorticoid Receptor Antagonists for Chronic Kidney Disease in Type 2 Diabetes: A Step Change in Treatment?

352

Behavioral Symptoms in Alzheimer's Disease: Getting Into Focus With Agitation

353

Establishing Better Standards of Practice: Maximizing Patient Outcomes With Noninvasive Screening in Nonalcoholic Fatty Liver Disease

354

Best Practices in the Care of Adult Patients With Spinal Muscular Atrophy

355

Novel Antipsychotic Therapies: A Review of Non-D2 Mechanisms and Implications for Care

356

Understanding IgA Nephropathy: Evolving Insights Into Disease State Pathophysiology as a Foundation for Novel Treatment Options

357

From Principles to Practice: Recent Data on Diagnosing Acute Upper Respiratory Tract Infections

358

Acute Kidney Injury After Cardiac Surgery: Expert Insights on Current Understanding

359

An Expert Panel Discussion on the Importance of Cytomegalovirus (CMV) Prevention and Congenital CMV Infection

360

Raising the Bar in Schizophrenia Care

361

Current Perspectives in Mood Disorders

362

Current Challenges in Child and Adolescent Psychiatry

363

Weight Gain and Women With HIV: Evolving Understanding and Optimizing Interventions

364

Controlling Dengue: Immunization Is a Pillar of Prevention

365

Driving Earlier Detection of Liver Fibrosis Outside of the Hepatology Clinic

366

Syndromic Testing for Joint Infections: What Is It and Why Should It Matter to You?

367

Improving Outcomes and Quality of Life in Advanced GIST: Discussing the Patient Journey and the Latest Data

368

Cultural Competence: Leveling the Playing Field in Mental Health

369

Geographic Atrophy: Why, When and How to Treat

370

Hot Off the Press From AHA Scientific Sessions 2022: Key Data and Clinical Conversations on Cardiovascular Risk Reduction

371

News on NASH – Selected Highlights From the AASLD Liver Meeting 2022

372

When Antiretroviral Treatment Adherence Really Matters: Consequences and Communication for People Living With HIV

373

The Importance of Non-invasive Screening in NAFLD

374

Listen to Your Gut: The Gut-Brain Axis, Nutrition, and Infant Neurodevelopment

375

Concepts to Practice: The Evolving Landscape in Topical Therapies for Plaque Psoriasis

376

Medical Dermatology Potpourri II

377

New Strategies to Advance Care for Women: Broadening Horizons for Quality Care in Women's Health

378

Health Equity in Dermatology

379

TAAR1: A New Target With Therapeutic Potential for Psychiatric Conditions, Focus on Schizophrenia

380

Assessing Risk in Hormone Receptor-Positive/HER2-Negative Early Breast Cancer: How to Approach Challenging Cases in the Clinic

381

Medical Dermatology Potpourri I

382

Case Review: Team-Based Approaches to Optimize Androgen Deprivation Therapy in Advanced Prostate Cancer

383

Confronting Racial and Ethnic Disparities in Cardioprevention: Actionable Insights to Enhance Patient Care

384

Module 2—Clinical Queries in Bipolar Depression: How Do You Provide Patient-Centered Care?

385

Biologics Targeting the IL-23/IL-17 Pathway in Psoriatic Disease: Treating Beyond the Skin

386

Lessons from the COVID Pandemic: Vaccines Are Essential Medicines Throughout the Life Course

387

Considering Health Equity in the Care of Patients With Alzheimer's Disease

388

Expert Perspectives on Improving Cardiovascular Disease Management in Women

389

Novel Once-Weekly Basal Insulins: Expert Interpretation of Latest Clinical Data

390

Does the Mechanism Matter? Breaking Down Novel Pharmacology in Bipolar Depression and Schizophrenia

391

Neurology Practice Updates

392

Migraine: A Review of Novel Therapeutics

393

Epilepsy: Expert Perspectives on Improving Outcomes

394

A Review of Rare Conditions Across the Lifespan: Pediatric Neuromuscular Disorders

395

Assessing Pruritus as Part of a Patient Visit for Dialysis

396

A Review of Rare Conditions Across the Lifespan: Adult Neuromuscular Disorders

397

Symptomatic Treatment of Sore Throat: Global Guidelines, Expert Perspectives and Best Practice

398

Ask the Expert: Focus on Frontline Treatment of Chronic Lymphocytic Leukemia

399

Optimizing Insomnia Management for the Elderly

400

Integrating Novel Strategies to Optimize Care of Patients With Chronic Graft vs Host Disease

401

European Society of Cardiology's Position on Renal Denervation: The Time Is Upon Us

402

Module 1: Clinical Queries in Bipolar Depression: What Tools Are Best for Screening and Diagnosis?

403

Key Considerations for the Topical Management of Psoriasis in Patients of Color

404

HIV Pearls for Primary Care: Recognizing and Managing Heavily Treatment-Experienced Patients With HIV

405

The Renal Denervation Durability Question Put to Rest

406

From Clinical Trials to Clinical Practice: Assessment of Insomnia Using Appropriate Scales

407

Optimizing Care of Patients With Chronic Lymphocytic Leukemia: Clinical Pearls for Nurses and Pharmacists

408

Abbreviated Liver MRI in Clinical Practice

409

PARP Inhibitor Combination Regimens for Prostate Cancer Management

410

Are We Ready for More BTK Inhibitors in Chronic Lymphoblastic Leukemia? Experts Discuss the Latest Data

411

Case Conversations in the Recognition and Management of Seizures in Tuberous Sclerosis Complex

412

Chronic Spontaneous Urticaria: Frequently Asked Questions

413

Comprehensive Management of a Patient on Dialysis With Pruritus

414

Pharmacologic Stress MRI for Assessment of Chest Pain Syndrome

415

Exploring HIV Management for HHS Recommendations: "Certain Clinical Situations"

416

Novel Treatment Options for CKD in Type 2 Diabetes – Evaluating Latest Landmark Trial Results

417

Supplemental Screening for Breast Cancer: Who, When, and How?

418

Respiratory Syncytial Virus Infection in Adults: Why It Should Be on Your Radar

419

How Important Is Sleep Architecture for Sleep Quality?

420

Prioritizing Pediatric Care for Managing Rare Tumors: Targeting NTRK Fusions as a Case Study

421

Countdown in Critical Care: Syndromic Testing for Bloodstream Infections

422

Rapid and Accurate Diagnosis in Meningitis & Encephalitis: Tips to Utilize Syndromic Testing in Practice

423

Demystifying the Role of Aspirin for Stroke Prevention

424

Current Evidence on the Use of Acetaminophen and NSAIDs for the Treatment of Osteoarthritis

425

Relationship Between Osteoarthritis, Inflammation, and Pain: A Closer Examination

426

Raising the Bar in HPV Screening - Power of Informed Prevention and Triage in Clinical Practice

427

Exploring Emerging Topical Treatments in Psoriasis: Are You Up to Date?

428

Roadmaps for Reducing High Blood Pressure

429

Latest Insights on Optimizing Outcomes in Chronic Thromboembolic Pulmonary Hypertension

430

Spotlight on Skin of Color in Dermatology

431

The Psoriasis Forum

432

Pediatric Pearls for Practice

433

Atopic Dermatitis Updates

434

Medical Dermatology Potpourri I

435

From the Plant to the Patient: Review of the Processes for Identifying and Producing Cannabidiol

436

Unfolding the Future of Alzheimer's Disease: What Primary Care Physicians Should Know

437

Where Are We With Real-Time Continuous Glucose Monitoring in Type 2 Diabetes?

438

Diagnosing and Managing Spasticity in Multiple Sclerosis: Team-Based Approach for Better Care

439

Pre-Exposure Prophylaxis for the Primary Care Provider

440

Digging Deep to Understand the Significance of Cytomegalovirus

441

Diagnostic Technologies: Elevating Antimicrobial Stewardship to the Next Level

442

Prostate Cancer Detection With MRI: Supporting Evidence and the Importance of Image Quality

443

Pulmonary Arterial Hypertension: Applying the Recommended Treatment Approaches

444

Time Matters in Alzheimer's Disease: A Patient Journey From Suspicion to Diagnosis

445

A Critical Review of Learnings From the '21 Clinical Trials on Alzheimer's Disease Conference

446

Bruton Tyrosine Kinase Inhibitors in Chronic Lymphocytic Leukemia: Context and Impact of New Data

447

State of the Art Care in Alzheimer's Disease: Exploring the Role of Biomarkers

448

A 360-Degree View of the Patient and Family Journey With Cytomegalovirus

449

Updates in Treating Newly Diagnosed Multiple Myeloma

450

A Better Option for Patients With Atrial Fibrillation Undergoing Transcatheter Aortic Valve Implantation

451

Manipulating the Disrupted Sleep-Wake Cycle in Insomnia

452

Maximizing the Heart Failure Pre-Discharge Toolkit: The Utility of Natriuretic Peptide Biomarker Assessment

453

Including the Patient Perspective in Pulmonary Arterial Hypertension Management

454

Over-the-Counter Analgesics/Antipyretics: Essential Medicines, Indispensable Medicines

455

Clinical Updates: Emerging Therapies for Patients With Multiple Myeloma

456

Improving Recognition of Heart Failure in Patients With Type 2 Diabetes: Prognostic Implications of Cardiac Biomarkers

457

Challenging Cases in Alzheimer's Disease: Applying Strategies to Inform Timely and Accurate Diagnosis

458

The Role of Biomarkers in HR-Positive/HER2-Negative Early Breast Cancer: From Clinical Analysis to Clinical Decisions

459

Optimizing the Management of Squamous Cell Carcinoma of the Head and Neck With Immunotherapeutic Strategies

460

Allergy Treatment: When Are Intranasal Corticosteroids and Antihistamines Appropriate?

461

Hot Topics in Over-the-Counter Options for Osteoarthritis: Topical vs Oral Analgesics

462

New Guidance on Managing Patients on Aspirin for Secondary Cardioprevention

463

Practical Insights for High-Risk Patients From the 2021 European Heart Rhythm Association Practical Guide on the Use of Non-Vitamin K Antagonist Oral Anticoagulants in Patients With Atrial Fibrillation

464

The Value of High-Sensitivity Cardiac Troponin Protocols for Optimal Patient Management: It's About Time

465

BCMA-Directed Therapy in Multiple Myeloma: Assessing the Clinical Impact

466

Optimizing Over-the-Counter Treatment of Nasal Congestion

467

Treatments for Bipolar Depression: Where We Are and Where We Are Going

468

OTC Analgesics/Antipyretics in a Post-Pandemic World: Rational Guidance for Improved Outcomes

469

Short Bowel Syndrome: Building Excellence in Care Across Your Multidisciplinary Teams

470

Insomnia in Practice: Understanding Causes and Consequences

471

From Evidence to Best Practices in Advanced GIST: Expert Analysis of the Latest Data

472

Advances in Pulmonary Artery Hypertension Care: Highlights From 2021 Congresses

473

Listening to Patient Preferences to Overcome Poor Adherence: Is This the Key to Better BP Control?

474

Caring for Patients With Advanced Basal Cell Carcinoma: Perspectives From the Interprofessional Team

475

What's New for BTK Inhibitors in B-Cell Malignancies? A Winter Hematology Conference Update

476

Device-Based CV Care

477

Managing Atopic Dermatitis in Skin of Color: A Case-Based Discussion

478

Data Updates on the Use of On-Demand Therapies in Parkinson Disease

479

Digital Therapeutics and Devices in ADHD: Use in Clinical Settings

480

Ask Your Mentor: The Patient With Cognitive Symptoms

481

Best Practices in Narcolepsy: The Role of Dosing for Improving Outcomes With Sodium Oxybate

482

Advances in Digital Therapeutics and Devices in ADHD: A Review of the Evidence

483

Ask Your Mentor: MDD and Comorbid Conditions

484

PAH Management: Getting It Right Early to Optimize the Clinical Course

485

What Is on the Horizon for Managing Disease-Associated Growth Failure in Infants?

486

Precision Management of Migraine: A Guide to the Use of Preventive Therapies

487

Best Practices for the Myeloma Care Team: Optimizing Outcomes for Patients With R/R Multiple Myeloma

488

Safe and Effective Use of New Therapies for Diabetic Kidney Disease: Patient Selection Is Key

489

Exploring Novel Approaches With PI3K Inhibitors in R/R Follicular and Marginal Zone Lymphoma

490

Moving Beyond COVID-19: Syndromic Testing for Respiratory Tract Infections

491

2021-2022 Update: The Essential Guide for Nurses in HIV

492

Diagnosis and Management of Skeletal Dysplasias/Achondroplasia: Experts Weigh In

493

Syndromic Testing in the Era of COVID-19: A Strategic Approach to Pathogen Identification for Pneumonia

494

New Frontiers in Sustained Delivery: New Data and Surgical Advances for Age-Related Macular Degeneration and Diabetic Eye Disease

495

Putting the Patient at the Center of Major Depressive Disorder Care

496

Ask Your Mentor: MDD Treatment Modification

497

From Interpretation to Application: Syndromic Testing for Gastroenteritis

498

Reducing the Risk of Recurrence In HR+/HER2- Early Breast Cancer Requires Action: MDT Clinical Case Discussions

499

Defining the Core Role of Primary Care in the Early Recognition of Alzheimer's Disease

500

Ask Your Mentor: Depression Screening via Telemedicine

501

Through the Looking Glass: What Is the View on Eosinophilic Gastrointestinal Diseases?

502

Cases From the Clinic: A Perspective on Managing Schizophrenia in Community Practice

503

A 20/20 Perspective on Barrier Repair and Skin Care in Pediatric and Primary Care

504

The Science Behind the First COVID-19 Vaccines

505

Improving MRI Workflow: The Value of Abbreviated Protocols

506

The Nurse View on BTK Inhibitors: Optimizing Your Care of Patients with CLL

507

BTK Inhibitors in CLL: Summer Data Updates and Expert Perspectives

508

Communication Conundrums: Tips and Techniques for Addressing Questions About HPV Immunization

509

Clinical Pearls for Pharmacists: BTK Inhibitors for the Treatment of CLL

510

State of Care: A Closer Look at OAB in LTC Facilities

511

The Role of Retinoid Receptor Signaling in Acne Pathology, Pathophysiology, and Treatment

512

2021 Data Blitz From the American Headache Society Annual Scientific Meeting

513

Recent Updates on the Mutational and Treatment Landscape of Advanced GIST

514

SARS-CoV-2 Variants and Monoclonal Antibodies: What Do We Know?

515

Monoclonal Antibodies: Looking Beyond COVID-19

516

Out of Control: Perspectives on Worsening Trends in Blood Pressure Control Rates

517

Call to Action in the Hospital: Potassium Management in the Real World

518

Antibodies and Vaccines: Why We Still Need Post-Exposure Prophylaxis

519

Patient Questions and Expert Answers for Healthy Skin of Color

520

The Emerging Receptor Science in the Management of Schizophrenia

521

Emerging Practice Strategies for PI3K Inhibitors in Relapsed/Refractory Follicular Lymphoma

522

Barriers to Access and Connecting People to Care

523

Early Diagnosis of PAH: The Latest Tools and Approaches

524

Postexposure Prophylaxis for COVID-19 Prevention: Where Do We Stand?

525

Navigating the Management of Triple-Negative Breast Cancer: Immunotherapy Considerations

526

Expert Perspective Series: Tips for Addressing Patients FAQs About COVID-19 Vaccines

527

Expanding Targetable Treatment in Thyroid Cancer: NTRK Fusions

528

Diagnostic Pearls in EGIDs Beyond EoE

529

Evidence Update and Practical Perspectives: Monoclonal Antibodies for COVID-19 Treatment

530

Vaccines vs Monoclonal Antibodies for COVID-19: Complementary Approaches to Tackling the Pandemic

531

Expert Exchange: The Why, When, and How of "On-Demand" Therapies for Parkinson Disease

532

Bipolar Depression: Putting the Patient at the Center of Care

533

Year in Review: Perspectives on JAK Inhibitors for Atopic Dermatitis

534

Mirror, Mirror on the Wall: The Perception of Acne

535

Ask the Experts: What Practical Information Do I Need to Know About Cannabinoids?

536

Everything You Need to Know About ICIs in Gynecologic Cancers

537

The Role of Antibiotic Stewardship in the Management of Rosacea

538

Challenges and Opportunities in the Use of Monoclonal Antibody Therapy for COVID-19

539

Emerging Treatments for Diabetic Macular Edema: New Data

540

Neutralizing the Virus: A Focus on SARS-CoV-2–Specific Monoclonal Antibodies

541

Gene Testing for Limb-Girdle Muscular Dystrophy: What, When, How

542

Optimizing Access to Monoclonal Antibodies for COVID-19: US Perspective

543

Understanding the Potential of Antibodies for COVID-19

544

New Horizons in Neovascular Age-Related Macular Degeneration: Latest Data and Expert Thoughts on Emerging Therapies

545

Fundamentals of Eosinophilic Gastrointestinal Diseases: What You Need to Know

546

Practical Management of Prostacyclin Pathway Therapy: A Focus on the Patient Experience

547

Potassium and Acid Regulation: Clinical Implications for Clinicians

548

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Vaccines

549

Expert Perspectives in Best Practices in Osteoarthritis Care

550

Essential Updates in GI Immunotherapy: HCC and Esophageal Cancers

551

Timing Is of the Essence for Migraine Prevention

552

rtCGM in Primary Care: Quick Tips for the Busy Clinician

553

Treatment Algorithms in Melanoma: Evaluating Where We Are and Where We Are Headed

554

Antiplatelet Therapy to Prevent Stroke: Where Does Aspirin Fit In?

555

Key Considerations for Managing Patients With Bipolar Disorder: What the PCP Needs to Know

556

Principles and Practicalities: The Logistics of Bringing NAbs Into Patient Care

557

Special Populations and Immune Checkpoint Inhibitors: Are They Safe?

558

A Clinician's Guide to Improve Early Detection and Treatment of Homozygous Familial Hypercholesterolemia (HoFH)

559

Updates and Advances: The Latest Data on Neutralizing the COVID-19 Pandemic

560

Updates in the Management of Treatment-Naive CLL

561

Depression Clinic: Can You Manage These Patients?

562

A Journey Into the Patient Experience of Frequent Migraine: Lessons for the Clinician

563

Expanding the Pharmacist's Role in rtCGM Use and Education in Practice

564

From Women/For Women: Perspectives in HIV Care

565

Personalizing Progressive Metastatic CRC Treatment

566

Choosing PAH Treatment With Short- and Long-Term Goals in Mind

567

Early Identification and Management of Infants With Growth Failure

568

Back to Basics With Cannabinoids: Endocannabinoids vs Phytocannabinoids

569

Updates in the Treatment of Multiply Relapsed/Refractory Multiple Myeloma

570

Assessing Current and Emerging Options for the Management of Peripheral T-Cell Lymphoma

571

Updates on Immune Modulators in Lung Cancer: Have We Met the Need?

572

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Treatment and Vaccines

573

Targeted Alpha Therapies in Prostate Cancer

574

Strategies for Ending the Pandemic: A Multipronged Approach

575

Shifting the Balance Between the Immune System and Cancer: Moving Beyond the PD-1/PD-L1 Axis

576

Best Practices for Assessing and Managing Side Effects of CLL

577

Involving Patients With Relapsed/Refractory Multiple Myeloma in Decision Making

578

Treatment Advances in NTRK Gene Fusion-Positive Sarcoma: What Do You Need to Know?

579

Updates in Atopic Dermatitis from the European Allergy Meeting

580

Stories From the Field: Rapid Diagnostic Testing for Meningitis in the ED

581

On the Frontlines: Testing for SARS-CoV-2

582

Expert Perspectives on the Management of Advanced Thyroid Cancer: What's New?

583

New Treatment Options for High-Risk COVID-19 Patients With Mild to Moderate Disease

584

Treatment of Major Depressive Disorder: A Foundational Perspective

585

COVID-19 Evidence Updates: Optimizing Care During the Evolving Pandemic: Testing for SARS-CoV-2

586

Stories From the Field: Updates on Syndromic Testing for RTIs and COVID-19

587

Prostate Cancer: A PSA on nmCRPC Updates

588

Challenging Cases in NAFLD and NASH: Diagnosis

589

Case Studies in Children With Hemophilia A: Leveraging PK for Use With SHL FVIII Replacement Therapy

590

Foundations for Measurement-Based Care for MDD

591

Patient Selection for Aspirin Therapy: Implications for Primary Care

592

Case Discussions in the Early Recognition of Duchenne Muscular Dystrophy (DMD)

593

Compass to Topical Antioxidants in Cosmeceuticals: Why, What, When, and How?

594

Putting it Into (Best) Practice: Diagnostic Challenges and Opportunities in Pneumonia

595

360-Degree Management of CKD Patients to Delay/Prevent Progression to ESRD

596

Stories From the Field: Syndromic Testing for Meningitis/Encephalitis

597

Pathways to Prevention: Optimizing Influenza Vaccination in the Era of COVID-19

598

Stories from the Field: Syndromic Testing for Respiratory Tract Infections in the COVID Era

599

Diet, Loop Diuretics, and/or Potassium Binders to Manage Hyperkalemia?

600

Views on the Flu: Maximizing Vaccination Opportunities in the COVID-19 Era

601

Optimizing the Management of Therapy-Related Adverse Events Across the Continuum of Care in GIST

602

Mission Critical: Improving the Timeliness and Accuracy of SMA Diagnosis and Management

603

OTC Cough and Cold Medicines: Ensuring Effectiveness for the Appropriate Patients

604

Over-the-Counter Treatments for Primary Dysmenorrhea

605

Personalizing Aspirin Treatment for Primary Prevention: Evaluating the Latest Evidence on Coronary Artery Calcium

606

Making the Diagnosis: Addressing the Challenge of Polymicrobial Infections in Acute Gastroenteritis

607

The ADHD Care Transition from Adolescence to Adulthood: Tips for Lifelong Management

608

Guideline-Directed Therapy for Heart Failure: Challenges and Solutions

609

Episode 3: Addressing Common Challenges in Anticoagulation in Atrial Fibrillation

610

Immunotherapy and the COVID-19 Pandemic: Addressing Clinical Case Challenges in Lung Cancer

611

Changing Paradigms in the Management of Advanced GIST Implications and Application of New Strategies

612

Cardioprevention and Diabetes: Assessing the Role of Aspirin and Antiplatelets

613

New Data on Schizophrenia in 2020: A QuickFire Exchange Between Experts

614

Acne Journal Club: What's New in Disease Pathophysiology

615

Stories from the Field: Rapid Diagnostics for Meningitis and Encephalitis

616

The GI Tract and COVID-19: How to Cut Risks and Keep Control

617

Practical Pain Management for School Nursing Staff

618

Episode 2: Atrial Fibrillation and NOACs: Are They All the Same?

619

COVID-19: Vulnerable Populations: Expert Perspectives and Practical Considerations From the United States

620

Management of NASH: What Do the Data Tell Us So Far?

621

COVID-19: Situation Update, Practice Essentials, and Answers From European Experts

622

The Burden of Acne: Scarring of the Face and Trunk

623

Episode 1: Stroke Prevention in Atrial Fibrillation: Why Are Patients Undertreated?

624

Stories From the Field: Rapid Diagnostics for RTIs

625

Targeting the Virus: Advancing the Treatment for COVID-19

626

Moving to Specialist Care in Migraine: Improving the Use of Migraine Prevention

627

The Face of Sleepiness in OSA: Understanding the Patient Experience

628

Rosacea Journal Club: What's New in Disease Pathophysiology

629

The HIV Prevention Toolbox: Priorities for Patients and Providers

630

Expert Perspectives on Seizure Rescue Therapies: What's New and Why It Matters

631

Putting GI Risk in Perspective: How Safe Are OTC Analgesics?

632

A Quick Reference Guide to the Therapeutic Use of Cannabinoids in Epilepsy

633

Psoriasis Cases and Concepts: What Is Clear?

634

The Healthcare Provider's Role in Hyperkalemia Management

635

The Impact of COVID-19 on Your Oncology Clinic: Navigating Cancer Care in a New World

636

Cardiometabolic Considerations in Narcolepsy

637

Case Conversations and Expert Perspectives in the Use of Anti-CGRP Antibody Therapies in Migraine

638

Hospital-Based Care of Pain: The Role of NSAIDs in the Emergency Department and Urgent Care

639

Stroke Prevention in Atrial Fibrillation: Latest Guidelines and Recommendations

640

PrEP 1-2-3: A Step-by-Step Guide to Incorporating PrEP Into Practice

641

The Aesthetic Gameshow: How Would you Approach These Patients?

642

Virtual Grand Rounds: Hyperkalemia, CKD,and Resistant Hypertension

643

Factor Xa Inhibitors in CAD/PAD: Where Are We Today?

644

What the PCP Needs to Know About Bipolar Depression

645

Emerging Clinical Data in Heart Failure: What's the Latest?

646

New HFrEF Therapies in the Spotlight: A Countdown to Clinical Knowledge

647

COVID-19 Pandemic: Implications & Coping Strategies for the Patient With Obesity

648

Rediscovering the Clinical Benefits of Aspirin: Arriving at New Conclusions

649

Risk-Assessment and Treatment of Pulmonary Embolism

650

Examining the Role of Real-Time CGM in Pregnancy

651

New Paradigms in PAD: Guidelines and Recommendations

652

Hyperkalemia From In-Hospital to Hospital Discharge: How Big a Problem Is It?

653

Improving Management of Dyslipidemia: Making the Most of the Care Team

654

The Latest Advances in HFrEF: New Data From ACC 2020

655

Clinical Consult: Hyperkalemia in Patients With T2D and CKD

656

Factor Xa Inhibitors in PAD: Assessing the Latest Data

657

Screening for Elevated Potassium: Who, What, and When?

658

Step-By-Step Guide to RAAS Inhibitor Optimization in Eligible Patients

659

Nursing Pearls for Clinical Care of Patients on BTK Inhibitors

660

Treatment Considerations for Managing Pediatric Bipolar Depression: The Experts Weigh In

661

Expert Recommendations for Treating CLL With BTK Inhibitors

662

Updates for Pharmacists: Utilizing BTK Inhibitors for the Treatment of CLL

663

Schizophrenia Journal Club: What Does the New Research Show?

664

Appropriate Treatment of Atrial Fibrillation: Which Dose for Which Patient?

665

Patient Assessment and Diagnosis of Peripheral Artery Disease

666

Mineralocorticoid Receptor Blockade and CVD: What's the Story?

667

Cancer-Associated Thrombosis and the Role of NOACs

668

Optimizing Prophylaxis: Case Studies in Incorporating PK Data to Improve Patient Care

669

New Data, New Opportunities in Treating Patients With Schizophrenia

670

Updates in CLL: Data and Recommendations for Using BTK Inhibitors

671

The Evolving Science of Novel Targets in HFrEF: What Every Healthcare Professional Needs to Know

672

Improving COPD Outcomes: Ensuring Success With Nebulized Therapy

673

NASH 101: What You Need to Know Now

674

Psoriasis and Metabolic Syndrome: What Is the Relationship?

675

Mineralocorticoid Receptor Antagonists: Are They All Created Equal?

676

CKD in T2D: Earlier Patient Identification for Improved Outcomes

677

Digging Deep in CKD in T2D

678

Extended Treatment for Venous Thromboembolism: Making the Right Choice

679

Countdown to Clinical Knowledge in Psoriatic Arthritis

680

Factor Xa Inhibitors in Coronary Artery Disease: Data, Guidelines, and Implications for Clinical Care

681

The Latest in PAD: Guidelines, Data, and Expert Interpretation

682

What's New in NOACs in AF? Evaluating Emerging Evidence

683

Treating Pulmonary Embolism Today: What Do the New Guidelines Say?

684

Atrial Fibrillation in Patients With Renal Impairment: How to Manage

685

Psoriatic Arthritis: Pathogenesis and Novel Targeted Therapies

686

Aspirin in 2019: What Every Physician Needs to Know